João Paulo Machado Bergamaschi

Dr. João Paulo Machado Bergamaschi

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2012 in Interdisciplinary Perspectives on Infectious Diseases
Verified
Journal Article
Open access
PDF file
FWFernanda Wirth
Fernanda Wirth
LGLuciano Goldani
Luciano Goldani
This is an updated paper focusing on the general epidemiological aspects ofRhodotorulain humans, animals, and the environment. Previously considered nonpathogenic,Rhodotorulaspecies have emerged as opportunistic pathogens that have the ability to colonise and infect susceptible patients.Rhodotorulaspecies are ubiquitous saprophytic yeasts that can be recovered from many environmental sources. Several authors describe the isolation of this fungus from different ecosystems, including sites with unfavourable conditions. Compared toR. mucilaginosa,R. glutinisandR. minutaare less frequently isolated from natural environments. Among the few references to the pathogenicity ofRhodotorulaspp. in animals, there are several reports of an outbreak of skin infections in chickens and sea animals and lung infections and otitis in sheep and cattle. Most of the cases of infection due toRhodotorulain humans were fungemia associated with central venous catheter (CVC) use. The most common underlying diseases included solid and haematologic malignancies in patients who were receiving corticosteroids and cytotoxic drugs, the presence of CVC, and the use of broad-spectrum antibiotics. Unlike fungemia, some of the other localised infections caused byRhodotorula, including meningeal, skin, ocular, peritoneal, and prosthetic joint infections, are not necessarily linked to the use of CVCs or immunosuppression.

23 April 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
CSCristina Spadari
Cristina Spadari
FWFernanda Wirth
Fernanda Wirth
LLLuciana Lopes
Luciana Lopes
KIKelly Ishida
Kelly Ishida
Cryptococcosis is an important opportunistic infection and a leading cause of meningitis in patients with HIV infection. The antifungal pharmacological treatment is limited to amphotericin B, fluconazole and 5- flucytosine. In addition to the limited pharmacological options, the high toxicity, increased resistance rate and difficulty of the currently available antifungal molecules to cross the blood–brain barrier hamper the treatment. Thus, the search for new alternatives for the treatment of cryptococcal meningitis is extremely necessary. In this review, we describe the therapeutic strategies currently available, discuss new molecules with antifungal potential in different phases of clinical trials and in advanced pre-clinical phase, and examine drug nanocarriers to improve delivery to the central nervous system.

9 August 2020 in Mycoses
Verified
Journal Article
Closed access
PDF file
FWFernanda Wirth
Fernanda Wirth
KIKelly Ishida
Kelly Ishida

1 June 2009 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
FWFernanda Wirth
Fernanda Wirth
SPSimone U. Picoli
Simone U. Picoli
VCVlademir V. Cantarelli
Vlademir V. Cantarelli
AGAna L.S. Gonçalves
Ana L.S. Gonçalves
FBFlávia R. Brust
Flávia R. Brust
MBMichelle F. Barreto
Michelle F. Barreto
This study determined the prevalence of metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa in two hospitals located in the Southern part of Brazil and compare the performance of two different phenotypic tests. Thirty-one non-repetitive Pseudomonas aeruginosa isolates from various clinical samples from patients admitted to two hospitals located in Rio Grande do Sul, Brazil (twenty-three from a hospital in Porto Alegre City and eight isolates from a hospital in Vale dos Sinos Region). All strains suggestive of possessing MBLs by phenotypic methods were included in this study. Phenotypic detection of MBLs was carried out simultaneously by using both the MBL Etest® and disk approximation test using 2-mercaptopropionic acid close to a ceftazidime disk. Strains positive were further confirmed using molecular techniques for blaVIM, blaIMP and blaSPM-1. The prevalence of MBLs from samplesof inpatients from the hospital located in Porto Alegre was 30.4% and that of inpatients from Vale dos Sinos hospital was only 3.1%. Only MBL type SPM-1 was detected in these samples by molecular analysis and all were detected by the Etest® MBL strips. The prevalence of P. aeruginosa that produce MBLs can be markedly different in distinct geographical areas, even among different hospitals in the same area. In our study, the EDTA-based method was the only method able to detect all strains harboring the SPM-1 enzyme

1 March 2017 in Journal of Medical Mycology
Verified
Journal Article
Closed access
RMR.-A. Maciel
R.-A. Maciel
LFL.-S. Ferreira
L.-S. Ferreira
FWFernanda Wirth
Fernanda Wirth
PRP.-D. Rosa
P.-D. Rosa
MAM. Aves
M. Aves
LGLuciano Goldani
Luciano Goldani

16 February 2011 in Mycoses
Verified
Journal Article
Closed access
PDF file
DFDiego Rodrigues Falci
Diego Rodrigues Falci
RSRodrigo P. dos Santos
Rodrigo P. dos Santos
FWFernanda Wirth
Fernanda Wirth
LGLuciano Goldani
Luciano Goldani